Dec 16, 2016
Australian court increases fine over 'misleading' Nurofen
The ACCC said the company had profited substantially from misleading customers on products including Nurofen Back Pain, Nurofen Period Pain, Nurofen Migraine Pain and Nurofen Tension Headache. In a statement to the BBC, Nurofen said it acknowledged the court's decision but would seek legal advice. "Nurofen is disappointed by this decision, as it considers that the original penalty of the Federal Court in April was appropriate in all of the circumstances," the statement read. The court in April ruled that Reckitt Benckiser had contravened Australian consumer law by saying its Nurofen Specific Pain products were each formulated to treat a specific type of pain. The company said: "Nurofen did not intend to mislead consumers, however we recognise that we could have done more to assist our consumers in navigating the Nurofen Specific Pain Range." Earlier this year, Reckitt Benckiser removed a TV advert for one of its products - Nurofen Express.
Related companies
Make a complaint about Nurofen by viewing their customer service contacts.
